Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Long Term Outcomes and Prognostic Factors of N0 Stage Nasopharyngeal Carcinoma: a Single Institutional Experience with 610 Patients

  • Sun, Jian-Da (Department of Radiation Oncology, Cancer Hospital of Shantou University Medical College) ;
  • Chen, Chuang-Zhen (Department of Radiation Oncology, Cancer Hospital of Shantou University Medical College) ;
  • Chen, Jian-Zhou (Department of Radiation Oncology, Cancer Hospital of Shantou University Medical College) ;
  • Li, Dong-Sheng (Department of Radiation Oncology, Cancer Hospital of Shantou University Medical College) ;
  • Chen, Zhi-Jian (Department of Radiation Oncology, Cancer Hospital of Shantou University Medical College) ;
  • Zhou, Ming-Zhen (Department of Radiation Oncology, Cancer Hospital of Shantou University Medical College) ;
  • Li, De-Rui (Department of Radiation Oncology, Cancer Hospital of Shantou University Medical College)
  • Published : 2012.05.30
Download PDF
⟨ Previous Next ⟩

Abstract

Treatment responses of $N_0$ stage nasopharyngeal carcinoma were firstly analyzed comprehensively to evaluate long term outcomes of patients and identify prognostic factors. A total of 610 patients with $N_0$ NPC, undergoing definitive radiotherapy to their primary lesion and prophylactic radiation to upper neck, were reviewed retrospectively. Concomitant chemotherapy was administrated to 65 out of the 610. Survival rates of the patients were calculated using the Kaplan-Meier method and compared by log-rank test. Prognostic factors were identified by the Cox regression model. The study revealed the 5-year and 10-year overall, disease-free, disease-specific, local failure-free, regional failure-free, locoregional failure-free and distant metastasis-free survival rates to be 78.7% and 66.8%, 68.8% and 55.8%, 79.9% and 70.4%, 81.2% and 72.5%, 95.8% and 91.8%, 78.3% and 68.5%, 88.5% and 85.5%, respectively. There were 192 patients experiencing failure (31.5%) after radiotherapy or chemoradiotherapy. Of these, local recurrence, regional relapse and distant metastases as the first event of failure occurred in 100 (100/610, 16.4%), 15(15/610, 2.5%) and 52 (52/610, 8.5%), respectively. Multivariate analysis showed that T stage was the only independent prognostic factor for patients with $N_0$ NPC (P=0.000). Late T stage (P=0.000), male (P=0.039) and anemia (P=0.007) were independently unfavorable factors predicting disease-free survival. After treatment, satisfactory outcome wasgenerally achieved in patients with $N_0$ NPC. Local recurrence represented the predominant mode of treatment failure, while T stage was the only independent prognostic factor for overall survival. Late T stage, male gender, and anemia independently predicted lower possibility of the disease-free survival.

Keywords

References

  1. Chua DT, Sham JS, Choy DT (2004). Prognostic impact of hemoglobin levels on treatment outcome in patients with nasopharyngeal carcinoma treated with sequential chemoradiotherapy or radiotherapy alone. Cancer, 101, 307-16. https://doi.org/10.1002/cncr.20366
  2. Gao J, Hu JY, Xia YF, et al (2010). Continuous fall in hemoglobin level is a poor prognostic factor in patients with nasopharyngeal carcinoma treated with radiotherapy. Chin J Cancer, 29, 561-6. https://doi.org/10.5732/cjc.009.10533
  3. Gao Y, Zhu G, Lu J, et al (2010). Is elective irradiation to the lower neck necessary for $N_{0}$ nasopharyngeal carcinoma? Int J Radiat Oncol Biol Phys, 77, 1397-402. https://doi.org/10.1016/j.ijrobp.2009.06.062
  4. Han L, Lin SJ, Pan JJ, et al (2010). Prognostic factors of 305 nasopharyngeal carcinoma patients treated with intensitymodulated radiotherapy. Chin J Cancer, 29, 145-50. https://doi.org/10.5732/cjc.009.10332
  5. Kam MK, Teo PM, Chau RM, et al (2004). Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience. Int J Radiat Oncol Biol Phys, 60, 1440-50. https://doi.org/10.1016/j.ijrobp.2004.05.022
  6. Lai SZ, Li WF, Chen L, et al (2011). How does intensitymodulated radiotherapy versus conventional twodimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients. Int J Radiation Oncology Biol Phys, 80, 661-8. https://doi.org/10.1016/j.ijrobp.2010.03.024
  7. Lee AWM, Sze WM, Au JSK, et al (2005). Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience. Int J Radiat Oncol Biol Phys, 61, 1107-16. https://doi.org/10.1016/j.ijrobp.2004.07.702
  8. Lee AW, Tung SY, Chan AT, et al (2006). Preliminary results of a randomized study (NPC-9902 Trial) on therapeutic gain by concurrent chemotherapy and/or accelerated fractionation for locally advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys, 66, 142-51. https://doi.org/10.1016/j.ijrobp.2006.03.054
  9. Leung TW, Tung SY, Sze WK, et al (2005). Treatment results of 1070 patients with nasopharyngeal carcinoma: an analysis of survival and failure patterns. Head Neck, 27, 555-65. https://doi.org/10.1002/hed.20189
  10. Min HQ, Hong MH, Ma J, et al (1994). A new staging system for nasopharyngeal carcinoma in China. Int J Radiat Oncol Biol Phys, 30, 1037-42. https://doi.org/10.1016/0360-3016(94)90307-7
  11. Ng WT, Chan SH, Lee AW, et al (2008). Parapharyngeal extension of nasopharyngeal carcinoma: still a significant factor in era of modern radiotherapy? Int J Radiat Oncol Biol Phys, 72, 1082-9. https://doi.org/10.1016/j.ijrobp.2008.02.006
  12. Ng WT, Lee AWM, Kan WK, et al (2007). N-staging by magnetic resonance imaging for patients with nasopharyngeal carcinoma:Pattern of nodal involvement by radiological levels. Radiother Oncol, 82, 70-5. https://doi.org/10.1016/j.radonc.2006.11.010
  13. Palazzi M, Guzzo M, Tomatis S, et al (2004). Improved outcome of nasopharyngeal carcinoma treated with conventional radiotherapy. Int J Radiat Oncol Biol Phys, 60, 1451-8. https://doi.org/10.1016/j.ijrobp.2004.05.059
  14. Rades D, Stoehr M, Kazic N, et al (2008). Locally advanced stage IV squamous cell carcinoma of the head and neck: impact of pre-radiotherapy hemoglobin level and interruptions during radiotherapy. Int J Radiat Oncol Biol Phys, 70, 1108-14. https://doi.org/10.1016/j.ijrobp.2007.07.2380
  15. Taheri-Kadkhoda Z, Pettersson N, Björk-Eriksson T, et al (2008). Superiority of intensity-modulated radiotherapy over three-dimensional conformal radiotherapy combined with brachytherapy in nasopharyngeal carcinoma: a planning study. Br J Radiol, 81, 397-405. https://doi.org/10.1259/bjr/36110151
  16. Tang L, Mao Y, Liu L, et al (2009). The volume to be irradiated during selective neck irradiation in nasopharyngeal carcinoma: Analysis of the spread patterns in lymph nodes by magnetic resonance imaging. Cancer, 115, 680-8. https://doi.org/10.1002/cncr.24049
  17. Teo PM, Leung SF, Lee WY, et a1 (2000). Intracavitary brachytherapy significantly enhances local control of early T-stage nasopharyngeal carcinoma: the existence of a dosetumor- control relationship above conventional tumoricidal dose. Int J Radiat Oncol Biol Phys, 46, 445-58. https://doi.org/10.1016/S0360-3016(99)00326-0
  18. Teo PM, Leung SF, Tung SY, et a1 (2006). Dose-response relationship of nasopharyngeal carcinoma above conventional tumoricidal level: a study by the Hong Kong nasopharyngeal carcinoma study group (HKNPCSG). Radiother Oncol, 79, 27-33. https://doi.org/10.1016/j.radonc.2006.03.012
  19. Tham IW, Hee SW, Yeo RM, et al (2009). Treatment of nasopharyngeal carcinoma using intensity-modulated radiotherapy-the national cancer centre singapore experience. Int J Radiat Oncol Biol Phys, 75, 1481-6. https://doi.org/10.1016/j.ijrobp.2009.01.018
  20. Wang XS, Hu CS, Ying HM, et al (2009). Patterns of retropharyngeal node metastasis in nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys, 73, 194-201. https://doi.org/10.1016/j.ijrobp.2008.03.067
  21. Wolden SL, Chen WC, Pfister DG, et al (2006). Intensitymodulated radiation therapy (IMRT) for nasopharynx cancer: Update of the Memorial Sloan-Kettering experience. Int J Radiat Oncol Biol Phys, 64, 57-62. https://doi.org/10.1016/j.ijrobp.2005.03.057
  22. Wong FC, Ng AW, Lee VH, et al (2010). Whole-field simultaneous integrated-boost intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys, 76, 138-45. https://doi.org/10.1016/j.ijrobp.2009.01.084
  23. Xie FY, Peng M, Hu WH, et al (2010). Prophylactic irradiation of cervical lymph nodes for Stage-N0 nasopharyngeal carcinoma. Chin J Cancer, 29, 106-10.
  24. Yeh SA, Tang Y, Lui CC, et a1 (2005). Treatment outcomes and late complications of 849 patients with nasopharyngeal carcinoma treated with radiotherapy alone. Int J Radiat Oncol Biol Phys, 62, 672-9. https://doi.org/10.1016/j.ijrobp.2004.11.002
  25. Yi JL, Gao L, Huang XD, et al (2006). Nasopharyngeal carcinoma treated by radical radiotherapy alone: Ten-year experience of a single institution. Int J Radiat Oncol Biol Phys, 65, 161-8. https://doi.org/10.1016/j.ijrobp.2005.12.003

Cited by

  1. A randomized clinical trial comparing prophylactic upper versus whole-neck irradiation in the treatment of patients with node-negative nasopharyngeal carcinoma vol.119, pp.17, 2013, https://doi.org/10.1002/cncr.28201
  2. Reirradiation with Robotic Stereotactic Body Radiotherapy for Recurrent Nasopharyngeal Carcinoma vol.15, pp.8, 2014, https://doi.org/10.7314/APJCP.2014.15.8.3561
  3. Role of regenerating gene IA expression on local invasion and survival in nasopharyngeal carcinoma vol.50, pp.1, 2017, https://doi.org/10.1186/s40659-017-0142-7
  4. STAT3 mediates resistance to anoikis and promotes invasiveness of nasopharyngeal cancer cells vol.40, pp.5, 2017, https://doi.org/10.3892/ijmm.2017.3151
  5. Feasibility of ipsilateral lower neck sparing irradiation for unilateral or bilateral neck node-negative nasopharyngeal carcinoma: systemic review and meta-analysis of 2, 521 patients vol.13, pp.1, 2018, https://doi.org/10.1186/s13014-018-1087-x